Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

SOL fell to $149.46 Tuesday after a late-evening sell-off erased earlier gains, though some institutional analysts continue ...

Analysts have set 12-month price targets for NVIDIA, revealing an average target of $166.06, a high estimate of $210.00, and ...

Gemini has filed a complaint against the Enforcement Division of the Commodity Futures Trading Commission (CFTC). The crypto ...